Atsuyoshi Seki

Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan

Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa et al. · Investigational New Drugs · 2019 · 82 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma

Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka et al. · Liver Cancer · 2020 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Keisuke Koroki, Naoya Kanogawa, Susumu Maruta et al. · Liver Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice

Miyuki Nakagawa, Masanori Inoue, Sadahisa Ogasawara et al. · Cancer · 2022 · 27 citations

Medicine, Oncology, Pharmacology +15

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

Sae Yumita, Sadahisa Ogasawara, Miyuki Nakagawa et al. · BMC Gastroenterology · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +17